Spots Global Cancer Trial Database for soft tissue sarcomas

Every month we try and update this database with for soft tissue sarcomas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients	NCT02575066	Sarcoma Soft Tissue Sar...	external beam r... pazopanib	18 Years -	The Netherlands Cancer Institute
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas	NCT00881595	Soft Tissue Sar...	Chemoradiothera... Proton therapy Proton Chemorad...	55 Years -	University of Florida
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors	NCT02536183	Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor...	Magnetic resona... Lyso-thermosens...	- 30 Years	Children's National Research Institute
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma	NCT03946943	Soft Tissue Sar... Undifferentiate...	Anlotinib Toripalimab Blood Draw Tumor Specimen ...	16 Years -	The First Hospital of Jilin University
11C-Acetate PET/CT Non-FDG-Avid Tumors	NCT00687778	Soft Tissue Sar... Thyroid Cancer Lung Cancer Indolent Lympho... Neuroendocrine ... GIST Uterine Maligna... Carcinoma, Hepa... Carcinoma, Lobu... Teratoma		18 Years - 90 Years	Tel-Aviv Sourasky Medical Center
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.	NCT03085225	Ovarian Carcino... Soft Tissue Sar...	Combination of ...	18 Years -	Institut Bergonié
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas	NCT02636725	Alveolar Soft P... Soft Tissue Sar...	Axitinib Pembrolizumab	16 Years -	University of Miami
RAD001 in Advanced Sarcoma	NCT01830153	Soft Tissue Sar... Bone Sarcomas	RAD001	17 Years -	Asan Medical Center
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors	NCT02536183	Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor...	Magnetic resona... Lyso-thermosens...	- 30 Years	Children's National Research Institute
PP-Gemcitabine & External Beam Radiation-Sarcomas	NCT02046304	Sarcoma	Gemcitabine Radiation Thera...	-	M.D. Anderson Cancer Center
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance	NCT06202599	Bone Sarcoma Soft Tissue Sar... Refractory Tumo...	Fruquintinib	-	Peking University People's Hospital
Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients	NCT02575066	Sarcoma Soft Tissue Sar...	external beam r... pazopanib	18 Years -	The Netherlands Cancer Institute
Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas	NCT03149120	Soft Tissue Sar...	Nivolumab Pazopanib	18 Years - 100 Years	NYU Langone Health
PP-Gemcitabine & External Beam Radiation-Sarcomas	NCT02046304	Sarcoma	Gemcitabine Radiation Thera...	-	M.D. Anderson Cancer Center
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors	NCT02574728	Cancer	Sirolimus Celecoxib Etoposide Cyclophosphamid...	12 Months - 30 Years	Emory University
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas	NCT06385288	Soft Tissue Sar...	Blood and tissu... neoadjuvant The...	18 Years -	University Hospital Tuebingen
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.	NCT03085225	Ovarian Carcino... Soft Tissue Sar...	Combination of ...	18 Years -	Institut Bergonié
Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas	NCT04506008	Soft Tissue Sar...	Ultra-Hypo-frac... Resection Questionnaire A... Moderately-Hypo...	18 Years -	Vanderbilt-Ingram Cancer Center
Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas	NCT04425967	Soft Tissue Sar...	pre-operative r...	18 Years -	The Netherlands Cancer Institute
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas	NCT00881595	Soft Tissue Sar...	Chemoradiothera... Proton therapy Proton Chemorad...	55 Years -	University of Florida
Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule	NCT04223583	Soft Tissue Sar...	Anlotinib Hydro...	18 Years - 70 Years	Henan Cancer Hospital
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).	NCT00385203	Gastrointestina... Soft Tissue Sar...	AZD2171	18 Years -	AstraZeneca
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas	NCT02636725	Alveolar Soft P... Soft Tissue Sar...	Axitinib Pembrolizumab	16 Years -	University of Miami
Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)	NCT00276302	Gastrointestina... Soft Tissue Sar...	IPI-504	18 Years -	Infinity Pharmaceuticals, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: